MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)
|
disease |
Eye Diseases
|
Disease or Syndrome
|
1
|
5
|
0.900 |
strong |
1.000 |
7 |
5
|
2003 |
2015 |
Diarrhea-negative hemolytic uremic syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2008 |
Complement abnormality
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Verotoxigenic Escherichia coli gastrointestinal tract infection
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Endocapillary glomerulonephritis
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Complement factor H measurement
|
phenotype |
|
Laboratory Procedure
|
1
|
5
|
0.100 |
None |
1.000 |
1 |
4
|
2017 |
2017 |
Disease due to Neisseria
|
disease |
Infections
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Retinal thrombosis
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Matrix Metalloproteinase 8 Measurement
|
phenotype |
|
Laboratory Procedure
|
1
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Sepsis caused by Pseudomonas aeruginosa
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Depletion of components of the alternative complement pathway
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Glomerular subendothelial electron-dense deposits
|
phenotype |
|
Anatomical Abnormality
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Meningococcal bacteraemia
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Renal disease (acute) NOS
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Pneumococcal sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Amphetamine or related acting sympathomimetic abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
furuncle
|
disease |
Infections; Skin and Connective Tissue Diseases; Animal Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Necrotizing glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Nonexudative age-related macular degeneration
|
disease |
Eye Diseases
|
Acquired Abnormality
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Drusen, Radial, Autosomal Dominant
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Familial hemolytic uremic syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
4
|
24
|
0.600 |
strong |
1.000 |
11 |
23
|
1998 |
2016 |
Properdin deficiency disease
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hemopexin measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
5
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Decreased serum complement factor H
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|